Abstract
A new triple tandem process has been discovered in which simple acyclic substrates can be transformed into bicyclic compounds via RCMdouble bond isomerization-cyclopropanation. This process is catalyzed by second generation Grubb's catalyst without the requirement of other reactives or additives. In addition, a one-pot RCM-isomerization reaction followed by cyclopropanation with CHCl3/NaOH allows the synthesis of products related to iNOS (nitric oxide synthase) inhibitors, which are currently under clinical evaluation.
| Original language | English |
|---|---|
| Journal | Organic Letters |
| Volume | 10 |
| Issue number | 4 |
| Pages (from-to) | 597-600 |
| Number of pages | 4 |
| ISSN | 1523-7060 |
| DOIs | |
| Publication status | Published - 21.02.2008 |
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)